церебральный венозный тромбоз - факторы риска и их кратное рисковое соотношение:
Twenty non-genetic (n = 2314) and 33 genetic (n = 2117) studies up to January 2017 met the selection criteria.
For non-genetic factors, CVT risk increased in the presence of
glucocorticosteroid therapy by 18.3-fold (3.3-102.6),
alcohol consumption 2.7-fold (1.8-3.9),
infection 7.5-fold (2.6-21.6),
surgery 9.6-fold (1.1-83.5),
hypercholesterolaemia 2.4-fold (1.3-4.4),
hyperhomocysteinaemia 3.1-fold (2.1-4.6),
antiphospholipid antibodies 7.0-fold (2.1-23.6),
autoimmune diseases 5.6-fold (2.3-13.6),
anaemia 4.0-fold (2.1-7.9),
malignancy 3.2-fold (1.4-7.1) and
pregnancy/puerperium 11.4-fold (5.7-24.3).
Smoking, hypertension and diabetes did not associate with CVT risk.
For genetic factors, CVT risk increased in the presence of
factor V Leiden (G1691A) by 2.5-fold (1.9-3.3),
protein C deficiency 10.7-fold (3.1-37.7),
protein S deficiency 5.7-fold (1.4-22.4),
antithrombin deficiency 3.8-fold (1.0-13.8),
prothrombin (G20210A) 5.5-fold (4.0-7.27) and
TAFI gene variant (C1040T) 1.6-fold (1.0-2.4).
[Ссылки доступны только зарегистрированным пользователям ]
__________________
Искренне,
Вадим Валерьевич.
|